Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy

BACKGROUND: Outpatient visits and laboratory assessments are routinely scheduled every 3 to 4 months in thiopurine-treated patients with inflammatory bowel disease (IBD) to timely detect thiopurine-related adverse events (AEs). AEs that require therapy adjustment beyond 12 months of treatment are ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Fenna M., Smits, Lisa J. T., Thomas, Pepijn W. A., de Jong, Dirk J., Kreijne, Joany E., van Dop, Willemijn A., den Broeder, Nathan, Hoentjen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293334/
https://www.ncbi.nlm.nih.gov/pubmed/37131100
http://dx.doi.org/10.1007/s10620-023-07950-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293334/
https://www.ncbi.nlm.nih.gov/pubmed/37131100
http://dx.doi.org/10.1007/s10620-023-07950-0

Ejemplares similares